WINTON GROUP Ltd Invests $1.66 Million in American Healthcare REIT, Inc. $AHR

WINTON GROUP Ltd purchased a new position in American Healthcare REIT, Inc. (NYSE:AHR) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 35,176 shares of the company’s stock, valued at approximately $1,655,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Harvest Fund Management Co. Ltd boosted its stake in shares of American Healthcare REIT by 13.3% in the 4th quarter. Harvest Fund Management Co. Ltd now owns 4,528 shares of the company’s stock worth $213,000 after buying an additional 533 shares during the last quarter. Vise Technologies Inc. purchased a new position in shares of American Healthcare REIT in the 4th quarter worth $524,000. Daiwa Securities Group Inc. boosted its stake in shares of American Healthcare REIT by 5.9% in the 4th quarter. Daiwa Securities Group Inc. now owns 443,678 shares of the company’s stock worth $20,879,000 after buying an additional 24,588 shares during the last quarter. State of Wyoming boosted its stake in shares of American Healthcare REIT by 80.3% in the 4th quarter. State of Wyoming now owns 13,124 shares of the company’s stock worth $618,000 after buying an additional 5,846 shares during the last quarter. Finally, WCG Wealth Advisors LLC boosted its stake in shares of American Healthcare REIT by 7.6% in the 4th quarter. WCG Wealth Advisors LLC now owns 24,583 shares of the company’s stock worth $1,157,000 after buying an additional 1,742 shares during the last quarter. 16.68% of the stock is currently owned by hedge funds and other institutional investors.

American Healthcare REIT Price Performance

NYSE AHR opened at $45.67 on Tuesday. The company has a market capitalization of $8.80 billion, a PE ratio of 78.74, a price-to-earnings-growth ratio of 1.59 and a beta of 0.80. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.45 and a current ratio of 0.45. The business’s fifty day moving average is $49.22 and its 200 day moving average is $49.30. American Healthcare REIT, Inc. has a fifty-two week low of $34.72 and a fifty-two week high of $54.67.

American Healthcare REIT (NYSE:AHR) last released its earnings results on Thursday, May 7th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.34). The company had revenue of $650.77 million for the quarter, compared to analysts’ expectations of $667.57 million. American Healthcare REIT had a net margin of 4.23% and a return on equity of 3.33%. American Healthcare REIT’s revenue for the quarter was up 20.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.38 earnings per share. American Healthcare REIT has set its FY 2026 guidance at 2.030-2.090 EPS. Sell-side analysts predict that American Healthcare REIT, Inc. will post 2.06 earnings per share for the current year.

American Healthcare REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, April 17th. Shareholders of record on Tuesday, March 31st were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $1.00 dividend on an annualized basis and a yield of 2.2%. American Healthcare REIT’s dividend payout ratio (DPR) is currently 172.41%.

Wall Street Analyst Weigh In

AHR has been the topic of several analyst reports. Citigroup reiterated a “market outperform” rating on shares of American Healthcare REIT in a research report on Monday, March 2nd. KeyCorp lifted their target price on American Healthcare REIT from $55.00 to $58.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. The Goldman Sachs Group set a $60.00 target price on American Healthcare REIT in a research report on Monday, March 2nd. Truist Financial lifted their target price on American Healthcare REIT from $52.00 to $57.00 and gave the company a “buy” rating in a research report on Thursday, March 12th. Finally, Royal Bank Of Canada lifted their target price on American Healthcare REIT from $54.00 to $56.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, American Healthcare REIT presently has a consensus rating of “Moderate Buy” and an average price target of $55.64.

Insider Buying and Selling

In other American Healthcare REIT news, EVP Mark E. Foster sold 2,000 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $48.32, for a total transaction of $96,640.00. Following the sale, the executive vice president directly owned 55,495 shares of the company’s stock, valued at $2,681,518.40. This trade represents a 3.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.75% of the stock is currently owned by corporate insiders.

American Healthcare REIT Company Profile

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare?related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long?term net lease or triple?net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high?growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.